Alia M Aldahlawi

Title: Alia M Aldahlawi: Innovator in Targeted Cancer Treatment

Introduction

Alia M Aldahlawi is a prominent inventor based in Jeddah, Saudi Arabia. She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a focus on improving drug delivery systems, Aldahlawi has developed groundbreaking formulations aimed at enhancing the efficacy of cancer therapies.

Latest Patents

Aldahlawi holds 2 patents related to her work in targeted drug delivery. Her latest patent involves the oral administration of 5-fluorouracil (5-FU) in a gelling nanosuspension designed for targeted delivery to treat colorectal cancers. This sustained-release formulation utilizes a polymeric coating in a nanosuspension comprising sodium alginate and carrageenan for oral administration. The nanosuspension forms an insoluble sedimenting gel in the low pH environment of the stomach, which accelerates gastric emptying. Once in the small intestine, the sedimented gel becomes soluble, allowing it to be transported to the colon where 5-FU is released at a predictable rate. This targeted delivery mechanism minimizes the loss of 5-FU in the gastrointestinal tract and enhances its exposure to cancerous cells in the colon.

Career Highlights

Aldahlawi is affiliated with King Abdulaziz University, where she continues her research and development efforts. Her work has garnered attention for its potential to revolutionize cancer treatment protocols and improve patient outcomes.

Collaborations

Throughout her career, Aldahlawi has collaborated with notable colleagues, including Sahar R El Hadad and Samaa T Abdullah. These partnerships have contributed to the advancement of her research and the successful development of her patented technologies.

Conclusion

Alia M Aldahlawi stands out as an innovative inventor in the field of cancer treatment, with her patented formulations showcasing her commitment to improving therapeutic strategies. Her work not only highlights her expertise but also reflects the potential for significant advancements in medical science.